Recognition of a virus-encoded ligand by a natural killer cell activation receptor

Hamish R.C. Smith, Jonathan W. Heusel, Indira K. Mehta, +10

Proceedings of the National Academy of Sciences

ImmunologyViral PathogenesisNk CellsImmunologic MechanismAntigen Processing +17

In vivo developmental stages in murine natural killer cell maturation

Sung‐Jin Kim, Koho Iizuka, Hyun-Seok P. Kang, +4

Nature Immunology

Cell LineageDevelopmental BiologyLymphocyte DevelopmentImmune Cell DevelopmentImmunology +8

<i>In vivo</i>natural killer cell activities revealed by natural killer cell-deficient mice

Sung‐Jin Kim, Koho Iizuka, Héctor L. Aguila, +2

Proceedings of the National Academy of Sciences

Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up

Sylvia Adams, Jennifer R. Diamond, Erika Hamilton, +9

JAMA Oncology

Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors

Koho Iizuka, Olga V. Naidenko, Béatrice Plougastel-Douglas, +2

Nature Immunology

Molecular ImmunologyNatural Killer CellsMedicineImmunologyTumor Immunity +6

Cd47 (Integrin-Associated Protein) Engagement of Dendritic Cell and Macrophage Counterreceptors Is Required to Prevent the Clearance of Donor Lymphohematopoietic Cells

Bruce R. Blazar, Frederik P. Lindberg, Elizabeth Ingulli, +5

The Journal of Experimental Medicine

Cell TherapyDendritic CellInnate Immune SystemImmunologyImmunologic Mechanism +19

Requirement for membrane lymphotoxin in natural killer cell development

Koho Iizuka, David Chaplin, Yang Wang, +4

Proceedings of the National Academy of Sciences

Safety and clinical activity of 1L atezolizumab + bevacizumab in a phase Ib study in hepatocellular carcinoma (HCC).

Stacey Stein, Michael J. Pishvaian, Michael Sangmin Lee, +7

Journal of Clinical Oncology

ImmunologyLethal CancerPathologyPharmacotherapyImmunotherapeutics +19

Efficacy and safety of atezolizumab (atezo) and bevacizumab (bev) in a phase Ib study of microsatellite instability (MSI)-high metastatic colorectal cancer (mCRC).

Howard S. Höchster, Johanna C. Bendell, James M. Cleary, +6

Journal of Clinical Oncology

ImmunologyImmunoeditingPathologyImmunotherapeuticsImmunotherapy +23

A Ligand for the Murine NK Activation Receptor Ly-49D: Activation of Tolerized NK Cells from β2-Microglobulin- Deficient Mice

Hiroshi Furukawa, Koho Iizuka, Jennifer Poursine‐Laurent, +2

The Journal of Immunology

Tolerized Nk CellsNk CellMedicineImmunologyImmune Regulation +13